Molecule.one leverages artificial intelligence (AI) to design novel chemical syntheses. As a response to the outbreak of the Covid-19 pandemic, the Polish start-up based in Warsaw has set out on the mission to accelerate the process of creating medicines.
Change is happening this very minute in the logistics industry. Why? Quite simply, because shippers are under enormous pressure from their customers to provide accurate real-time visibility data on shipments from pick-up to delivery.
Iris.ai was founded at Singularity University at NASA Ames Research Park in 2015. Challenged to come up with an idea that would positively impact the lives of 1 billion people, the team was formed and problem areas were explored.
As discovery accelerates and throughput rises, digital transformation is becoming essential for chemistry labs. AI, robotics, and data growth must be orchestrated to boost productivity—rather than overwhelm the lab.